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AbstrAct 
Aims Reports into standards in the National Health 
Service and quality in pathology have focused on the 
way we work in pathology and how to provide assurance 
that this is of a high standard. There are a number of 
external quality assurance schemes covering pathology 
and histopathology specifically; however, there is no 
scheme covering the process of histological surgical 
dissection. This is an area undergoing development, 
emerging from the sole preserve of medically qualified 
pathologists to a field populated by a number of highly 
trained biomedical scientists, but remains without any 
formal quality assurance.
Methods This work builds on Barnes, taking the 
guidance of the Royal College of Pathologists (RCPath)
and Institute of Biomedical Science (IBMS)to form 
a series of key performance indicators relating to 
dissection. These were developed for use as an indicator 
of individual practice, highlighting areas of variation, 
weakness or strength. Once identified, a feedback event 
provided opportunities to address these errors and 
omissions, or to enable areas of strength to be shared.
results The data obtained from the checklists 
demonstrate a large variation in practice at the outset 
of this study. The use of the checklists alone served to 
reduce this variation in practice, the addition of the 
training event showed further reduction in variation. The 
combination of these two tools was an effective method 
for enhancing standardisation of practice.
conclusions The results of this work show that training 
events serve to reduce variation in practice by, and 
between, dissectors, driving up standards in dissection—
directly addressing the needs of the modern pathology 
service.
IntroductIon
There have been many reviews of practice and 
standards in the National Health Service in recent 
years,1–4 the first and last of those being of most 
importance to the histopathology laboratory. The 
review into practices at King’s Mill Hospital4 ulti-
mately found no misdiagnosis; however, a number 
of serious concerns were identified into the funding 
and organisation of the laboratory, attitude of the 
trust management to the pathology department, 
training and equipment; the most significant 
concern was in regard to the External Quality Assur-
ance (EQA) scheme which gave rise to the original 
concern. The review reported that the EQA scheme 
did not adequately consider the sample size and 
the statistical safety of extrapolating from the data, 
nor were the results sufficiently meaningful as to 
provide direction and specificity to their concerns. 
The report also detailed concerns regarding the 
methods used by an external agency appointed to 
investigate the issue; their apparent identification 
of ‘weak positivity’ of oestrogen receptor (ER) 
staining, which they claimed had erroneously been 
reported as negative, was in fact false positives. The 
original report of ER negative was correct. This 
gave rise to another investigation, this time by Dr 
Barnes. The Barnes Report1 covered quality control 
in pathology and was quite exhaustive in nature. 
Barnes noted the reports from Francis and Sher-
wood Forrest, and echoed a number of their find-
ings, calling for open, transparent individual quality 
data and standardisation of practice in pathology. 
The national EQA scheme in histopathology is 
run by UK National External Quality Assessment 
Service (UKNEQAS)5; the results generated by this 
scheme are fed back to the individual laboratory 
along with regional average rates. It is not possible 
to draw direct parallels between laboratories, nor 
is it possible for non-members of the scheme to 
view the data. Where a laboratory fails to meet the 
minimum standard, a letter is sent to the nominated 
‘technical head’ UKNEQAS.5 This clearly does not 
fit within the framework of openness, account-
ability and transparency.
This work goes some way to addressing this 
failing. Barnes1 noted that quality procedures in 
pathology were no longer fit for purpose and called 
for individually identifiable, evidence-based, key 
performance indicators (KPI). This work examines 
the evidence base for practices in surgical dissec-
tion in diagnostic histopathology, and establishes 
the premise of using KPIs to identify deviations in 
practice. It looks at how to feedback these data to 
the personnel involved, with methods of encour-
aging a collaborative team approach to determining 
best practice and optimising performance. Further, 
as biomedical scientist (BMS) led specimen dissec-
tion is an emerging field, this work looks to estab-
lish an objective standard of practice by providing 
comparison with the current practice, performed by 
consultant histopathologists.
This paper investigates the feasibility of devel-
oping KPIs to measure adherence to a specified 
process of histopathological surgical dissection. 
Data collected using these KPIs will be used to 
highlight variation in practice by and between indi-
viduals working in a histopathology laboratory/
setting. Some reflection on the implications of this 
process and how to address any variation will then 
be considered.
KPI may be an unfamiliar concept within 
pathology; however, it is something that is already 
in use, although informally. Histopathologists 
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reporting colorectal cancer specimens are encouraged to self-
audit their reports on an annual basis for the following criteria:
1. The median number of lymph nodes examined should be 
greater than 12.
2. The frequency of serosal involvement should be at least 20% 
for colonic cancers and 10% for rectal cancers.
3. The frequency of venous invasion, including intramural 
(submucosal and intramuscular) and extramural, should be 
at least 30%.6
While this guidance has been in place since at least 2006, in 
the second edition of the colorectal cancer reporting dataset 
guideline document from the Royal College of Pathologists 
(RCPath),7 there is little evidence that this has been done. 
There is certainly no transparency around this activity and the 
results.
A more recent and more structured attempt to make use of 
KPI in pathology again comes from the RCPath. Reacting to 
Barnes1 and his calls for quality data, the RCPath produced a 
response detailing the sort of KPI that could be used to assess 
the quality of the pathology service.8 This work specified a 
number of different areas of activity, generally at a departmental 
level, such as turnaround times, rather than on the standards of 
individual practice. The RCPath has continued to develop this, 
and has built these many KPIs into a performance dashboard, 
monitoring multiple criteria, rather than attempting to reduce 
this to a single datum.9
An important question is what, if any, steps are, can be or 
should be taken when good or poor performance is detected. 
Within pathology, we have a long tradition of professional 
independence; this has not ensured universal high quality,10 
the intention of the published dashboards is to allow public 
scrutiny, and to provide information to Clinical Commissioning 
Groups (CCG). While the possibility of patients choosing to 
use other hospitals, and the risk of CCGs electing to purchase 
services elsewhere is a strong motivator, it is an indirect one.
A more direct investigation of methods to reward or sanction 
good and poor practice is outside the scope of this work, but is 
certainly needed.
The objectives of this research are to:
 ► create a set of histopathological dissection KPIs based on the 
best available professional and scientific guidance;
 ► collect performance data in relation to the KPIs from a num-
ber of dissectors working in one histopathology setting.
MAterIAls And Methods
Four checklists were created to assess the dissection quality of 
appendix, gallbladder, uterus and colon specimens based on 
the work of Pronovost et al.11 The items on the checklist were 
those either mandated in the RCPath tissue pathway, RCPath 
minimum data set or were required by the local Standard Oper-
ating Procedure (SOP).
These checklists were deployed in several rounds of data 
collection, with the introduction of a training event after the 
collection of initial baseline data. Approximately 50 checklists 
for each specimen type were completed, and the data were tabu-
lated against an anonymous unique identifier for the dissector.
A training event was created to feedback and review the find-
ings of the checklists. The training event comprised a short case 
review by a consultant pathologist highlighting areas of good 
and poor practice.
The checklists were deployed in a number of rounds with the 
training event running on a weekly basis. The training event was 
removed at two points (months 5 and 7) to enable the effective-
ness of the checklists to be assessed in isolation.
results
The checklists were tabulated to demonstrate how each dissector 
conformed to each point on the list. The data are presented for 
each specimen type in figure 1.
The appendix and gallbladder were included as they are rela-
tively simple organs, with a well-established and agreed protocol 
for handling, description and sampling. Despite this, the above 
graph shows a tremendous variation in protocol at the outset. 
The uterus samples comprised a range of specimens from simple 
atrophic hysterectomy to complex malignancies. Again, the 
protocols for these are well developed.
changes over time for all specimen types
The mean for all SOP conformance across all specimen types is 
plotted (figure 2) for each dissector. The high level of variation 
seen in the individual parts is evident. The overall trends that can 
be discerned show that the checklists have the most effect on the 
most people. When the checklists are withdrawn and other inter-
ventions run in their place, the average conformance drops. The 
use of diagrams alone saw the average conformance drop for one of 
the BMS and two of the pathologists. Reintroducing the checklists 
Figure 1 Mean of average conformance to Standard Operating Procedure (SOP), by specimen type, for all dissectors, all parts. This figure 
demonstrates the change in means for adherence to SOP for all dissectors in each round, broken down by specimen type. The error bars indicate 1 
SD, demonstrating the range of values. The chart clearly shows that conformance to SOP overall increases throughout each round, and a reduction in 
variance between dissectors is seen, by the reduction in size of the error bars.
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stabilises the drop, and the reintroduction of the training event 
brings most dissectors to an average of 100% for all KPIs.
In table 1, we can compare the changes in mean for each 
round against the baseline, and consider the SD. Also included 
is a column demonstrating the t-test statistic, comparing each 
round against the baseline data.
dIscussIon
The results from the data collection, indicating the starting point, 
show considerable variation in the way that individuals handle 
and describe specimens. The appendix analysis demonstrated a 
clear split in the BMS group, with different sampling practices 
between the two groups. The differences highlight variation in 
practice, which leads to greater error rates and worse patient 
outcomes.12–15 The data from the pathologists demonstrated a 
broad conformity; one pathologist was noted to show the same 
variance in sampling seen in one BMS group. Investigation into 
the discrepancy revealed that the difference was due to a change 
in the SOP, of which some people were unaware. The change 
had been made over a year previously to bring the sampling in 
Figure 2 This graph plots the overall conformance to Standard Operating Procedure (SOP) for each dissector (as assessed by the checklists and 
report review), for each stage of the study. While a great deal of variance is seen, a clear trend towards 100% conformance is seen over time for the 
majority of practitioners over each round. Some variation returns, and for some dissectors the amount of variation is in itself quite variable. BMS, 
biomedical scientist.
table 1 Mean of mean conformance to Standard Operating Procedure (SOP), mean of SD within these data and SD of the means—all dissectors, 
all specimen types, all rounds. The table demonstrates the increase in conformance to SOP over time, and a reduction in SD over time
stage Activity Mean of means, % Mean of sd sd of means t-test
Part 1 Baseline data 67.38 26.27 10.69
n=5 BMS, 7 pathologists, checklists=50 appendix, 50 gallbladder, 50 uterus, 50 colon
Part 2 Checklist introduction 79.83 25.02 14.71 0.366
n=5 BMS, 7 pathologists, checklists=48 appendix, 50 gallbladder, 43 uterus, 48 colon
Part 3 Training event and 
checklists
89.42 18.11 12.45 0.089
n=5 BMS, 7 pathologists, checklists=50 appendix, 50 gallbladder, 50 uterus, 50 colon
Part 4 Training event only 92.52 17.91 5.95 0.021
n=5 BMS, 7 pathologists, checklists=50 appendix, 50 gallbladder, 50 uterus, 50 colon
Part 5 Guide diagrams 94.23 10.23 3.27 0.018
n=5 BMS, 7 pathologists, checklists=50 appendix, 50 gallbladder, 50 uterus, 50 colon
Part 6 Training event and guide 
diagrams
96.41 6.12 4.09 0.012
n=5 BMS, 5 pathologists, checklists=50 appendix, 50 gallbladder, 50 uterus, 50 colon
Part 7 Checklists only 90.16 14.49 12.55 0.078
n=5 BMS, 0 pathologist, checklists=46 appendix, 43 gallbladder, 39 uterus, 48 colon
Part 8 Training event and 
checklists
97.38 2.38 0.37 0.016
n=6 BMS, 8 pathologists, checklists=46 appendix, 48 gallbladder, 43 uterus, 49 colon
BMS, biomedical scientist.
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line with the RCPath guidelines; however, these staff members 
were somehow unaware of the change. The results from the gall-
bladder show a similar split in sampling and description across 
two groups. This variance with the dissectors revealed a differ-
ence in training of the BMS staff. BMS 1, 2 and 5 had been 
trained by one consultant and BMS 3 and 4 had been trained by 
a different consultant. The difference related to the site of the 
sampling—the fundus is the area that should be sampled. BMS 
1, 2 and 5 had been doing this; however, BMS 3 and 4 had been 
taking a transverse section through the body of the gallbladder. 
The fundus should be sampled as this is considered by the lead 
gastrointestinal pathologist as the most likely site of any inci-
dental pathology. This triggered a review of the SOP, and the 
underlying reason for the preferred sampling was stated in the 
SOP. The updated SOP was communicated to the dissectors in a 
group meeting and the reason for this explained.
The colorectal data clearly demonstrate the application of 
the checklist and feedback sessions. There are far more data 
points for the colorectal than in the other specimen types, indi-
cating the higher level of complexity in these specimens; the 
wide variation in data seen from the first round of data collec-
tion shows how much variation in practice there is. All dissec-
tors should be working in the same way, yet the data clearly 
show that this is not the case. Even among the BMS dissectors 
that have been trained by the same people, there is still a vari-
ation. This variation completely disappeared from the BMS 
group with the introduction of the checklists, and this change 
persisted with the introduction of the training intervention. 
Two of the pathologists showed the same response, the others 
showed a more variable response. The two BMS are both in 
training and working towards an advanced level dissection 
examination; as such, they are both invested in their training 
and professional development. The pathologists are used to 
working under their own direction and making their own indi-
vidual judgements, rather than following a protocol. As such, 
it is perhaps unsurprising that their data output is more vari-
able. While there is no direct indication that these variations 
impacted on diagnosis, it does show unnecessary variation in 
practice, and extending this to malignant resections would be 
likely to show a diagnostic impact.
The variations are clear to see, as are the improvements with 
the introduction of the checklists. Comparison between the 
baseline and first round shows a distinct reduction in variation. 
The introduction of the checklists resulted in standardisation in 
practice. Having the checklists available at the point of dissec-
tion appears to have focused attention on the process of dissec-
tion and allowed dissectors to think more specifically about the 
specimen without distraction. Discussion with several of the 
dissectors has indicated that reading the checklists highlighted 
requirements that they had not been aware of and that some 
used the checklist as a memory prompt. The introduction of the 
checklist allowed dissectors to become aware of what informa-
tion was being collected. This prompted dissectors to ask ques-
tions and check the requirements of the SOP. One of the patholo-
gists felt that the presence of the checklists enabled the dissector 
to focus on the specific requirements of the complexities of the 
individual specimen, while using the checklist to ensure they 
were performing all of the mandatory operations and satisfying 
the demands of protocol.
The combination of the checklists running with the training 
event appears to be the most effective, both in terms of the level 
of reduction in variation and in terms of the level of engagement 
from the dissectors. Using the checklists to generate anonymous 
data to demonstrate what is occurring, rather than working 
from assumptions, but actually being able to demonstrate hard 
evidence, provides an intellectual ‘hook’ upon which the indi-
vidual can hang the new ideas and practices. The training event 
satisfies the BMS's desire for feedback, and creates a closer 
working relationship with the pathologists. As the pathologists 
seldom attend the training sessions run by another pathologist, 
this provides an opportunity for the BMS to make the patholo-
gist aware of conflicting requirements—for example, they have 
indicated that a procedure should be performed in a certain way, 
while their colleague has indicated it must not be done this way. 
This has sparked discussion between the pathologists, leading to 
discussion of their intent and motivation behind those decisions, 
ultimately resulting in a standard approach from the patholo-
gists.
One of the aims at the outset of this research was to inves-
tigate the use of KPIs in dissection and see if they could be 
applied to create a data set indicating performance standards. 
This has been achieved, the dissection checklists are based on 
the recommendations of the RCPath and local protocols, with 
best practice in surgery guidance used as a starting point. The 
specific data points on the checklist are less important than 
the checklist itself. As demonstrated in the Pronovost et al's 
study,11 checklists can be modified to suit the specific require-
ments of the individual environment, while still remaining a 
powerful tool for regional or national data collection. If this 
work forms the basis of a national framework to address the 
deficiencies highlighted by Barnes,1 a consensus on a set of 
key data points would need to be reached. Once these were 
agreed, the checklist might contain some optional points, and 
space for local protocol to add points that were important to 
that specific laboratory or region. As Bosk et al16 take great 
pains to point out, there was not one single checklist for the 
Keystone study,11 there were in fact over 100 versions. The 
checklists used in their study covered one procedure, the 
insertion of a central line catheter, and contained five key 
items. The intensive care unit departments taking part in the 
study were each encouraged to customise and develop the 
checklist to address the issues and culture within their own 
environment. In this study, four distinct checklists have been 
used for four different specimen types. Clearly, there is room 
for further development of the dissection checklists, enabling 
users in other laboratories to customise them according to 
their own needs is a feature, which has been considered from 
the outset.
This work has relied heavily on the identification of substan-
dard performance by Barnes.1 It is fitting then to consider how 
this work seeks to meet some of his recommendations.
2.22. Overall, the quality assurance framework in pathology lacks 
several key factors without which we cannot say the best interests 
of the patient are being served.
This work focuses extensively on demonstrating the use of KPIs, 
demonstrating the facility for transparency and oversight.
4.28. Further consideration must be given to the ways in which 
individual performance can be assessed, monitored and competence 
assured.
This work clearly sets out the basis for such a system, and proof 
of its effectiveness.
Further work ought to consider this variation, and how it 
might be addressed. While this work clearly demonstrates 
substantial variation in practice, and shows a decrease in vari-
ation with the introduction of the checklists, this is only the 
first step. Another of Barnes'1 recommendations was that there 
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ought to be a framework that allows for reward and sanction for 
good and poor performance. Such a mechanism is much needed, 
and if integrated with the use of the dissection KPI, would meet 
many of Barnes's requirements.
take home messages
 ► Histopathological dissection lacks a suitable form of quality 
control.
 ► Key performance indicators (KPI) can be used to 
demonstrate good and poor performance.
 ► Feedback of the KPI data increases standardisation.
 ► KPI identifies good practice, which can then be shared 
within teams.
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